RH Revenue Outlook Disappoints But Investors Still Undervaluing Stock -- Market Talk

Dow Jones
2025/09/12

09:53 ET -- RH reducing its full-year outlook was disappointing given previous commentary from the company, but investors are still undervaluing the company's fundamentals, says Stifel analyst W. Andrew Carter, who cuts RH's price target to $320 from $390 but maintains a buy rating. The company is seeing traction internationally and reported a stronger second-quarter free cash flow. But Carter acknowledges uncertainty around tariffs may limit investor interest. Regarding tariffs, "we believe RH would be positioned as a winner long-term, but the headwinds/performance through this first wave has fallen short of the posturing offered on the 4Q24 earnings call," Carter says. (nicholas.miller@wsj.com)

 

(END) Dow Jones Newswires

September 12, 2025 09:53 ET (13:53 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10